We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$171M
AUM Growth
-$4.07M
Cap. Flow
-$2.81M
Cap. Flow %
-1.64%
Top 10 Hldgs %
93.32%
Holding
41
New
Increased
4
Reduced
4
Closed
8

Top Buys

Rank Stock Value
1
ALDX icon
Aldeyra Therapeutics
ALDX
+$2.25M
2
ALT icon
Altimmune
ALT
+$604K
3
MAG
MAG Silver
MAG
+$380K
4
SA
Seabridge Gold
SA
+$114K

Sector Composition

Rank Sector Weight
1 Healthcare 91.85%
2 Materials 3.11%
3 Financials 0.99%
4 Industrials 0.7%
5 Consumer Staples 0.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABEO icon
26
Abeona Therapeutics
ABEO
$413M
$269K 0.16%
88,629
-1
-0% -$4
BTAI icon
27
BioXcel Therapeutics
BTAI
$27.8M
$236K 0.14%
1,250
CNTX icon
28
Context Therapeutics
CNTX
$44.5M
$155K 0.09%
139,520
ANVS icon
29
Annovis Bio
ANVS
$80M
$147K 0.09%
14,210
ORMP icon
30
Oramed Pharmaceuticals
ORMP
$179M
$130K 0.08%
20,000
SNGX icon
31
Soligenix
SNGX
$5.81M
$15K 0.01%
145
-988
-87% -$173K
AMD icon
32
Advanced Micro Devices
AMD
$789B
-8,200
Closed -$627K
ANET icon
33
Arista Networks
ANET
$238B
-55,200
Closed -$1.29M
ASML icon
34
ASML
ASML
$669B
-1,280
Closed -$609K
ELTX icon
35
Elicio Therapeutics
ELTX
$83.8M
-6,000
Closed -$68K
LUMN icon
36
Lumen
LUMN
$6.44B
-100,000
Closed -$1.09M
OSK icon
37
Oshkosh
OSK
$9.59B
-8,450
Closed -$694K
SPRO icon
38
Spero Therapeutics
SPRO
$73M
-70,000
Closed -$52K
AGTC
39
DELISTED
Applied Genetic Technologies Corporation
AGTC
-100,000
Closed -$77K

Similar funds

Knoll Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Knoll Capital Management held 41 positions worth $171M, down 2.3% from $175M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Knoll Capital Management's Q3 2022 filing shows 4 increased, 4 reduced and 8 closed positions. The largest sale was Arista Networks, an estimated $1.29M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 87% a quarter earlier, followed by Materials and Financials.

  • Knoll Capital Management added most to Aldeyra Therapeutics in Q3 2022, an estimated $2.25M increase.
  • Knoll Capital Management's biggest Q3 2022 reduction was Eiger BioPharmaceuticals, Inc., cutting an estimated $887K.
  • Knoll Capital Management fully exited Arista Networks in Q3 2022, selling an estimated $1.29M.
  • Knoll Capital Management's ten largest holdings make up 93% of its $171M portfolio in Q3 2022.
  • Knoll Capital Management opened 0 new positions and closed 8 in Q3 2022.
  • Knoll Capital Management's portfolio value fell 2.3% quarter-over-quarter to $171M.

Based on Knoll Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.